
zzso resistance zzso arise commonly following single or zzso zzso zzso prophylaxis to prevent zzso transmission zzso of human zzso virus zzso but zzso within zzso months of zzso zzso Use of zzso prophylaxis in infants is expected to rise, but data on zzso of zzso resistance zzso in infants in whom zzso failed remain zzso We zzso in Ethiopian infants participating in the zzso zzso zzso zzso zzso the prevalence and persistence of zzso resistance zzso at 6 and 12 months following zzso or up to 6 weeks of zzso and correlated their presence with the timing of infection and the type of resistance zzso Standard population zzso followed by zzso cloning were done on dried blood spot samples collected during the zzso More infants who received zzso had zzso resistance detected by standard population zzso zzso zzso at age 6 months compared with those who received zzso zzso zzso zzso of 24 zzso zzso of 19, zzso p zzso zzso Moreover, zzso of zzso infants with zzso resistance at age 6 months still had zzso resistance zzso present at high zzso at age 1 zzso zzso infected before 6 weeks of age who received either zzso or zzso were more likely to have zzso or zzso these zzso were also more likely to persist at high zzso through 1 year of zzso zzso infants in whom zzso prophylaxis fails are likely to experience delayed clearance of zzso virus in the first year of life, which in turn places them at risk for early selection of zzso zzso after initial therapy with zzso reverse zzso zzso zzso 

